Jun 30, 2018

Neurocrine Biosciences Q2 2018 Earnings Report

Total Revenue
$96.9M
Previous year: $6.34M
+1429.7%
EPS
-$0.07
Previous year: -$0.68
-89.7%
Gross Profit
$96.1M
Previous year: $6.27M
+1430.9%
Cash and Equivalents
$166M
Previous year: $309M
-46.2%
Free Cash Flow
$15.8M
Previous year: -$126M
-112.6%
Total Assets
$841M
Previous year: $754M
+11.6%

Neurocrine Biosciences

Neurocrine Biosciences